This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Breast Cancer
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Provided treatments

  • Drug: Fulvestrant

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02909361. The sponsor of the trial is Fudan University and it is looking for 500 volunteers for the current phase.
Official trial title:
A Multicenter, Prospective, Real-world Study to Evaluate the Safety Profile and Effectiveness in Chinese Patients Who Received Fulvestrant 500mg as First-line Endocrine Treatment for Advanced Breast Cancer